Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seongheon Kim

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
BMC Neurology|December 23, 2022
Health-related quality of life using WHODAS 2.0 and associated factors 1 year after stroke in Korea: a multi-centre and cross-sectional studyHey Jean Lee, Jung-Kook Song, Jiyoung Moon, et al.
Frontiers in Neurology|September 8, 2022
Predicting progression to dementia with "comprehensive visual rating scale" and machine learning algorithmsChaeyoon Park, Jae-Won Jang, Gihun Joo, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 6, 2020
Depressive Symptoms in Stroke Patients: Are There Sex Differences?Eun-Jae Lee, Jong S Kim, Dae-Il Chang, et al.
The Lancet. Psychiatry|December 26, 2016
Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled studyJong S Kim, Eun-Jae Lee, Dae-Il Chang, et al.
Journal of Geriatric Psychiatry and Neurology|September 11, 2020
Post-Stroke Depressive Symptoms: Varying Responses to Escitalopram by Individual Symptoms and Lesion LocationEun-Jae Lee, Jong S Kim, Dae-Il Chang, et al.
Journal of Stroke|June 12, 2018
Differences in Therapeutic Responses and Factors Affecting Post-Stroke Depression at a Later Stage According to Baseline DepressionEun-Jae Lee, Jong S Kim, Dae-Il Chang, et al.
Stroke|December 21, 2019
Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: Subgroup Analysis of the PICASSO TrialBum Joon Kim, Sun U Kwon, Joung-Ho Park, et al.
Scientific Reports|March 16, 2022
Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDMJungHyun Byun, Dong Yun Lee, Chang-Won Jeong, et al.
Journal of Neuroimmunology|April 7, 2016
Prevalence of antineuronal antibodies in patients with encephalopathy of unknown etiology: Data from a nationwide registry in KoreaJung-Ick Byun, Soon-Tae Lee, Keun-Hwa Jung, et al.
Contemporary Clinical Trials|November 27, 2025
Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trialWookjin Yang, Hee-Kwon Park, Seong-Ho Koh, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
BMC Neurology|December 23, 2022
Health-related quality of life using WHODAS 2.0 and associated factors 1 year after stroke in Korea: a multi-centre and cross-sectional studyHey Jean Lee, Jung-Kook Song, Jiyoung Moon, et al.
Frontiers in Neurology|September 8, 2022
Predicting progression to dementia with "comprehensive visual rating scale" and machine learning algorithmsChaeyoon Park, Jae-Won Jang, Gihun Joo, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 6, 2020
Depressive Symptoms in Stroke Patients: Are There Sex Differences?Eun-Jae Lee, Jong S Kim, Dae-Il Chang, et al.
The Lancet. Psychiatry|December 26, 2016
Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled studyJong S Kim, Eun-Jae Lee, Dae-Il Chang, et al.
Journal of Geriatric Psychiatry and Neurology|September 11, 2020
Post-Stroke Depressive Symptoms: Varying Responses to Escitalopram by Individual Symptoms and Lesion LocationEun-Jae Lee, Jong S Kim, Dae-Il Chang, et al.
Journal of Stroke|June 12, 2018
Differences in Therapeutic Responses and Factors Affecting Post-Stroke Depression at a Later Stage According to Baseline DepressionEun-Jae Lee, Jong S Kim, Dae-Il Chang, et al.
Stroke|December 21, 2019
Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: Subgroup Analysis of the PICASSO TrialBum Joon Kim, Sun U Kwon, Joung-Ho Park, et al.
Scientific Reports|March 16, 2022
Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDMJungHyun Byun, Dong Yun Lee, Chang-Won Jeong, et al.
Journal of Neuroimmunology|April 7, 2016
Prevalence of antineuronal antibodies in patients with encephalopathy of unknown etiology: Data from a nationwide registry in KoreaJung-Ick Byun, Soon-Tae Lee, Keun-Hwa Jung, et al.
Contemporary Clinical Trials|November 27, 2025
Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trialWookjin Yang, Hee-Kwon Park, Seong-Ho Koh, et al.
Pageof 6